These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26531326)

  • 41. The role of intestinal microbiota in cardiovascular disease.
    Jin M; Qian Z; Yin J; Xu W; Zhou X
    J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The roles of microbial products in the development of colorectal cancer: a review.
    Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
    Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The links between gut microbiota and obesity and obesity related diseases.
    Geng J; Ni Q; Sun W; Li L; Feng X
    Biomed Pharmacother; 2022 Mar; 147():112678. PubMed ID: 35134709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications.
    Muralitharan RR; Jama HA; Xie L; Peh A; Snelson M; Marques FZ
    Hypertension; 2020 Dec; 76(6):1674-1687. PubMed ID: 33012206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease.
    Chu H; Duan Y; Yang L; Schnabl B
    Gut; 2019 Feb; 68(2):359-370. PubMed ID: 30171065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
    O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
    Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions.
    Zhang LS; Davies SS
    Genome Med; 2016 Apr; 8(1):46. PubMed ID: 27102537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro by human intestinal microbiota of polysaccharides from Fuzhuan brick tea.
    Chen G; Xie M; Wan P; Chen D; Ye H; Chen L; Zeng X; Liu Z
    Food Chem; 2018 Apr; 244():331-339. PubMed ID: 29120790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short chain fatty acids in human gut and metabolic health.
    Blaak EE; Canfora EE; Theis S; Frost G; Groen AK; Mithieux G; Nauta A; Scott K; Stahl B; van Harsselaar J; van Tol R; Vaughan EE; Verbeke K
    Benef Microbes; 2020 Sep; 11(5):411-455. PubMed ID: 32865024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
    Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
    Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.
    Duizer C; de Zoete MR
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
    Nagatomo Y; Tang WH
    J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization.
    Guo S; Peng Y; Lou Y; Cao L; Liu J; Lin N; Cai S; Kang Y; Zeng S; Yu L
    Pharmacol Res; 2022 Mar; 177():106101. PubMed ID: 35104632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Semisynthetic bile acids: a new therapeutic option for metabolic syndrome.
    Lazarević S; Đanić M; Goločorbin-Kon S; Al-Salami H; Mikov M
    Pharmacol Res; 2019 Aug; 146():104333. PubMed ID: 31254667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble Dietary Fiber Reduces Trimethylamine Metabolism via Gut Microbiota and Co-Regulates Host AMPK Pathways.
    Li Q; Wu T; Liu R; Zhang M; Wang R
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28884952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.
    Onyszkiewicz M; Jaworska K; Ufnal M
    Exp Biol Med (Maywood); 2020 Jan; 245(2):166-175. PubMed ID: 31948289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.
    Poll BG; Cheema MU; Pluznick JL
    Physiology (Bethesda); 2020 Jul; 35(4):275-284. PubMed ID: 32490748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spent coffee grounds, an innovative source of colonic fermentable compounds, inhibit inflammatory mediators in vitro.
    López-Barrera DM; Vázquez-Sánchez K; Loarca-Piña MG; Campos-Vega R
    Food Chem; 2016 Dec; 212():282-90. PubMed ID: 27374534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The gut-bone axis: how bacterial metabolites bridge the distance.
    Zaiss MM; Jones RM; Schett G; Pacifici R
    J Clin Invest; 2019 Jul; 129(8):3018-3028. PubMed ID: 31305265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.